Skip to main content
OpenTrials

Clinical trial condition

Gastric / Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastric / Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

14 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Gastric / Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details
Not Yet Recruiting

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

NCT07700979

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric / Gastroesophageal Junction Adenocarcinoma, +6 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UCLA Health Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 25 locations
View Trial Details

Related conditions